Magenta Therapeutics, Inc. carries a market capitalization of 42.44M, placing it among publicly traded companies globally.
| Market Cap | 42.44M |
| Enterprise Value | N/A |
Magenta Therapeutics, Inc.'s stock has declined approximately -35.81651% over the past 52 weeks. The 50-day moving average sits at 0.78, while the 200-day moving average is 0.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.81651% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 0.73 |
| Average Volume (20 Days) | N/A |